Crossmark

Update on the pathophysiology and medical treatment of peripheral artery disease

Crossref DOI link: https://doi.org/10.1038/s41569-021-00663-9

Published Online: 2022-01-07

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Golledge, Jonathan https://orcid.org/0000-0002-5779-8848
License Information

Text and Data Mining valid from 2022-01-07

Version of Record valid from 2022-01-07
More Information

Article History

Accepted: 7 December 2021

First Online: 7 January 2022

Competing interests

: The author has received honoraria from Amgen and Bayer for giving lectures on PAD.